Long term results from a prospective database on high dose rate (HDR) interstitial brachytherapy for primary cervical carcinoma

详细信息    查看全文

• 作者：Julia Fallon ; BA ; Sang-Jung Park ; PhD ; Lisa Yang ; BMBS ; MS ; Darlene Veruttipong ; MPH ; Mingle Zhang ; BS ; Thanh Van ; BS ; Pin-Chieh Wang ; PhD ; Alexandra M. Fekete ; BS ; Mauricio Cambeiro ; MD¹ ; Mitchell Kamrava ; MD ; Michael L. Steinberg ; MD ; D. Jeffrey Demanes ; MD ; ^{jdemanes@mednet.ucla.edu}
• 刊名：Gynecologic Oncology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：144
• 期：1
• 页码：21-27
• 全文大小：411 K
• 卷排序：144

文摘

Brachytherapy (BT) is an essential component of radiation treatment of cervical cancer. Intracavitary (IC) BT often does not fully encompass the intended target. Interstitial (IS) brachytherapy provides access and better geometry for deep and complicated lesions. High dose rate (HDR) acts synergistically with interstitial implants to achieve optimal radiation dosimetry. Excellent long-term outcomes were achieved in advanced disease with HDR IS-BT.